Reaction #1951046
ord-21c417490ba04a10b01c9023d301c804
Reaction equation
compound 1
1,2,3,5-tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose
cytosine
SnCl4 acetonitrile
1,2,3,5-tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose
→
compound 2
4-amino-1-(3,4-dibenzoyloxy-5-benzoyloxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one
Reactants
Reagents
None
Conditions
Detailed conditions
See reaction.notes.procedure_details.
Workup
- 1OtherIn one synthesis method
Procedure
In one synthesis method, depicted in FIG. 5, the synthesis comprises reacting cytosine, BSA and SnCl4/acetonitrile with 1,2,3,5-tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose (FIG. 5, compound 1) to form 4-amino-1-(3,4-dibenzoyloxy-5-benzoyloxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (FIG. 5, compound 2); and reacting (FIG. 5, compound 2) with NaOMe/MeOH to provide 4-amino-1-(3,4-dihydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (FIG. 5, compound 3), also known as 2-C-methyl-β-D-ribofuranose. The use of cytosine as a starting material rather than benzoyl-cytosine improves the “atom economy” of the process and simplifies purification at later steps.